These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29416606)

  • 1. SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance.
    Wang Z; Xu X; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Tu Y
    Oncotarget; 2018 Jan; 9(1):192-204. PubMed ID: 29416606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.
    Li B; Zhao H; Song J; Wang F; Chen M
    Hum Cell; 2020 Jan; 33(1):159-174. PubMed ID: 31713817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
    Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
    Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autophagy in regulation of glioma stem cells population during therapeutic stress.
    Abbas S; Singh SK; Saxena AK; Tiwari S; Sharma LK; Tiwari M
    J Stem Cells Regen Med; 2020; 16(2):80-89. PubMed ID: 33414584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
    Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K
    Phytomedicine; 2024 Dec; 135():156070. PubMed ID: 39326139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide.
    Batara DC; Park SW; Kim HJ; Choi SY; Ohn T; Choi MC; Park SI; Kim SH
    Am J Cancer Res; 2023; 13(9):4021-4038. PubMed ID: 37818053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
    Sugimori M; Hayakawa Y; Boman BM; Fields JZ; Awaji M; Kozano H; Tamura R; Yamamoto S; Ogata T; Yamada M; Endo S; Kurimoto M; Kuroda S
    PLoS One; 2015; 10(8):e0135760. PubMed ID: 26284929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations.
    Sugimori M; Hayakawa Y; Tamura R; Kuroda S
    Oncotarget; 2019 Mar; 10(24):2397-2415. PubMed ID: 31040930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
    Wang SM; Lin WC; Lin HY; Chen YL; Ko CY; Wang JM
    Cell Death Discov; 2021 Jan; 7(1):8. PubMed ID: 33436575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.
    Leng L; Zhong X; Sun G; Qiu W; Shi L
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
    Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
    Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy.
    Hartheimer JS; Park S; Rao SS; Kim Y
    Cancer Microenviron; 2019 Apr; 12(1):47-56. PubMed ID: 31079324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
    Sestito S; Nesi G; Daniele S; Martelli A; Digiacomo M; Borghini A; Pietra D; Calderone V; Lapucci A; Falasca M; Parrella P; Notarangelo A; Breschi MC; Macchia M; Martini C; Rapposelli S
    Eur J Med Chem; 2015 Nov; 105():274-88. PubMed ID: 26498573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.
    Aldaz P; Martín-Martín N; Saenz-Antoñanzas A; Carrasco-Garcia E; Álvarez-Satta M; Elúa-Pinin A; Pollard SM; Lawrie CH; Moreno-Valladares M; Samprón N; Hench J; Lovell-Badge R; Carracedo A; Matheu A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.